Immunotherapy in Chronic Lymphocytic Leukemia: BCG Induced Long Term Remission
A case of chronic lymphocytic leukemia (C.L.L.) was treated with repeated administration of tumor dose Bacillus Calmette-Guerin (BCG). Following the first immunization series, the case has gone into complete remission and has remained so up to the time of this report, for about 9 years. The leukemic lymphocytes appeared to be "null” cell type.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).